Programmatic versus personalised approaches to managing the global epidemic of multidrug-resistant tuberculosis

Lancet Respir Med. 2020 Apr;8(4):334-335. doi: 10.1016/S2213-2600(20)30104-1. Epub 2020 Feb 27.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antitubercular Agents / therapeutic use*
  • Epidemics
  • Global Health*
  • Humans
  • Mycobacterium tuberculosis
  • National Health Programs*
  • Precision Medicine / methods*
  • Tuberculosis, Multidrug-Resistant / drug therapy*
  • Tuberculosis, Multidrug-Resistant / epidemiology

Substances

  • Antitubercular Agents